PCM
ACHN

Prelude Capital Management’s Achillion Pharmaceuticals ACHN Stock Holding History

Prelude Capital Management’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-22,900
Closed -$69K – 2049
2013
Q3 		$69K Buy
+22,900
New +$157K 0.01% 884

Prelude Capital Management's ACHN Position: Q1 2020 in Review

Prelude Capital Management sold out of Achillion Pharmaceuticals (ACHN) in Q1 2020, closing a stake of 33,635 shares — an estimated $203K sold.

Prelude Capital Management first reported a position in ACHN in Q2 2013 and held it in 6 quarters. The position peaked at $1.02M in Q2 2013. 0 funds tracked by Wall St. Rank hold ACHN as of Q1 2020.

  • Prelude Capital Management reported no remaining Achillion Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • Prelude Capital Management sold 33,635 Achillion Pharmaceuticals shares in Q1 2020, an estimated $203K.
  • Prelude Capital Management first reported a position in Achillion Pharmaceuticals in Q2 2013 and held it in 6 quarters.
  • Prelude Capital Management's Achillion Pharmaceuticals position peaked at $1.02M in Q2 2013.
  • 0 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q1 2020.

Based on Prelude Capital Management's 13F filing for Q1 2020, filed 15 May 2020.